Overview

The Effects of Using Yupingfeng Powder With Variation for the Treatment of Allergic Rhinitis

Status:
Not yet recruiting
Trial end date:
2023-03-31
Target enrollment:
0
Participant gender:
All
Summary
Allergic rhinitis (AR) is an IgE mediated chronic inflammatory disease of the upper airways characterized by symptoms of sneezing, rhinorrhea, nasal itching, and nasal obstruction . However, not only this disease is difficult to cure, but also its relapse rate is high, therefore exerting a certain impact on their daily life, work and study. Nowadays, the main treatment for allergic rhinitis is the use of western medicine, such as steroids and antihistamines. However, many clinical studies have found that the curative effect of western medicine is often not ideal. Allergic rhinitis belongs to the category of "Rhinitis" in Chinese medicine. From the perspective of Chinese medicine, this disease is resulted from the deficiency of Qi and Yang Qi in the lungs, spleen and kidneys. Therefore, according to Chinese medicine theory, tonifying lung and spleen qi is the treatment principle for AR patients. Among different Chinese herbal formulae for AR, Yupingfeng san is commonly used for allergic diseases and in AR patients, due to its warm nature and able to improve the functions of the lungs and spleen. Yupingfeng san can improve symptoms and quality of life, as well as decrease the levels of interleukin and IgE in AR patients. This study will use Yupingfeng Powder with variation to evaluate its effectiveness and safety in treating AR. Hence, this study would be able to provide evidence on the efficacy and safety of Yupingfeng Powder with variation for AR.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Prof. Lin Zhixiu
Criteria
Inclusion Criteria:

- Age d above 5;

- Subjects with deficiency of lung and spleen Qi;

- At least 2 or more allergic symptoms rhinorrhea , sneezing , nasal obstruction and
nasal itching for a cumulative period greater than 1 hour per day. These symptoms may
be accompanied by itchy and red eyes and tears;

- Positive srum IgE test;

- Voluntary written consent.

Exclusion Criteria:

- Known chronic disease such as asthma, rhinosinusitis, nasal polyposis;

- Known severe medical conditions, such as cardiovascular, liver or renal dysfunction,
diabetes mellitus, cancers, cerebrovascular diseases, blood system diseases;

- Concomitant steroid, nonsteroidal anti inflammatory drugs (NSAIDs), anticoagulant, and
immunotherapy within past month;

- Impaired hematological profile and liver / renal function;

- Known alcohol and / or drug abuse;

- Known allergic history to any Chinese herbal medicines;

- Subjects who are pregnant or lactating.